Singapore Biomed Panel Approves Funding Dengue, Metabolic Research
This article was originally published in PharmAsia News
Executive Summary
Singapore's biomedical sciences council has approved an infusion of $33.9 million into a pair of research programs to find treatments for dengue and metabolic diseases. The International Advisory Council also approved a partnership with the Duke University School of Medicine's clinical research institute in the United States. The partnership is to be used to help develop research capabilities at the Singapore Clinical Research Institute that coordinates and supports Phase III trials in Singapore. (Click here for more